Discordant Temporal Evolution of Pfcrt and Pfmdr1 Genotypes and Plasmodium falciparum In Vitro Drug Susceptibility to 4-Aminoquinolines after Drug Policy Change in French Guiana.

Authors: Legrand E Yrinesi J Ekala MT Péneau J Volney B Berger F Bouchier C Bertani S Musset L Meynard JB Mercereau-Puijalon O
Address: Address correspondence to Eric Legrand, elegrand@pasteur-cayenne.fr.
Journal:

Publication:

abstract

Analysis of the Evolution of Drug target genes under changing drug Policy is needed to assist monitoring of Plasmodium falciparum drug resistance in the field. Here we genotype Pfcrt and Pfdmr1 of 700 isolates collected in French Guiana from 2000 (5 years after withdrawal of chloroquine) to 2008, i.e., the period when the artemether-lumefantrine combination was progressively introduced and mefloquine was abandoned. Gene sequencing showed fixation of the 7G8-type Pfcrt SMVNT resistance haplotype and near fixation of the NYCDY Pfdmr1 haplotype. Pfdmr1 gene copy number correlated with 50% inhibitory concentrations of mefloquine and halofantrine (r = 0.64 and 0.47, respectively, n = 547); its Temporal Changes paralleled changes in in Vitro mefloquine Susceptibility. However, the molecular parameters studied did not account for the regained in vitro susceptibility to chloroquine and showed a poor correlation with susceptibility to artemether, lumefantrine, or quinine. Identification of novel markers of resistance to these antimalarials is needed in this South American area.

Related Articles
In vitro monitoring of Plasmodium falciparum drug resistance in French Guiana: a synopsis of continuous assessment from 1994 to 2005.
Antimicrob Agents Chemother. 2...
In vitro monitoring of Plasmodium falciparum drug resistance in French Guiana: a synopsis of continuous assessment from 1994 to 2005.
Legrand E, Volney B, Meynard JB, Mercereau-Puijalon O, Esterre P. Antimicrob Agents Chemother. 2008 Jan; 52(1):288-98. Epub 2007 Oct 22.
Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
Infect Genet Evol. 2011
Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
Lekana-Douki JB, Dinzouna Boutamba SD, Zatra R, Zang Edou SE, Ekomy H, Bisvigou U, Toure-Ndouo FS. Infect Genet Evol. 2011 Mar; 11(2):512-7. Epub 2011 Jan 17.
Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.
Malar J. 2010
Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.
Dlamini SV, Beshir K, Sutherland CJ. Malar J. 2010 Mar 3; 9:68. Epub 2010 Mar 3.
Review Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum.
Drug Resist Updat. 2006
Review Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum.
van Schalkwyk DA, Egan TJ. Drug Resist Updat. 2006 Aug-Oct; 9(4-5):211-26. Epub 2006 Oct 24.
Review The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum.
Fundam Clin Pharmacol. 2003
Review The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum.
Le Bras J, Durand R. Fundam Clin Pharmacol. 2003 Apr; 17(2):147-53.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.